Cytokine storm: An overreaction of the body's immune system published in new Scientist
At all material times, Aimsco has been the legal or beneficial owner of all intellectual property rights relating to the AIMSPRO® product and business, whether in the nature of patents, trade marks, confidential information or otherwise.
Note: As a result of a number of acts and omissions by Daval International, in 2016, under clause 6.2.2 of the Patent License, Aimsco Ltd. declared Daval in breach of the Patent License which was then revoked.
Any claims and / or allegations to the contrary are simply false.